Sector dividends Medtide Inc.

Stocks

3880

CNE100006S86

Biotechnology & Medical Research

Market Closed - Hong Kong S.E. 04:08:13 2026-09-22 EDT			5-day change	1st Jan Change
20.88 ^HKD	+4.56%		+10.30%	-31.50%

08-27	Medtide Inc. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
07-31	Medtide Names CFO	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Dividend Yield (N)	Dividend Yield (N+1)	P/E (N)	Price to Book (N)	EV / Sales (N)	EV / EBITDA (N)	EV / EBIT (N)	Capi.($)
MEDTIDE INC.	-.--%	-.--%	-	1.28x	3.76x	9.8x	10.94x	361M
LONZA GROUP AG	1.01%	1.17%	32.07x	4.28x	5.77x	17.28x	24.18x	46.68B
IQVIA HOLDINGS INC.	-.--%	-.--%	34.76x	6.35x	3.35x	14.44x	21.81x	44.42B
REVOLUTION MEDICINES, INC.	-.--%	-.--%	-19.81x	20.38x	213.44x	-21.53x	-19.99x	41.32B
BEONE MEDICINES AG	-.--%	-.--%	47.9x	8.11x	5.56x	30.41x	34.99x	41.58B
CELLTRION, INC.	0.41%	0.43%	27.45x	2.23x	7.91x	20.36x	23.85x	30.14B
MEDPACE HOLDINGS, INC.	-.--%	-.--%	35.5x	25.47x	5.83x	26.48x	27.7x	17.42B
EUROFINS SCIENTIFIC SE	1.03%	1.16%	26.02x	2.89x	2.23x	9.67x	14.99x	15.54B
TEMPUS AI, INC.	-.--%	-.--%	-56.03x	28.08x	9.2x	224.52x	-1707.27x	14.08B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-.--%	-.--%	76.26x	4.42x	3.95x	15.33x	18.81x	13.32B
ICON PUBLIC LIMITED COMPANY	-.--%	-.--%	28.78x	1.36x	1.89x	11.63x	13.25x	13.08B
BIO-TECHNE CORPORATION	0.44%	0.44%	52.45x	4.58x	8.71x	24.71x	29.47x	11.36B
PHARMARON BEIJING CO., LTD.	0.54%	0.67%	41.03x	4.78x	4.86x	20.75x	32.95x	11.35B
KYMERA THERAPEUTICS, INC.	-.--%	-.--%	-30.39x	8.83x	80.55x	-20.31x	-19.69x	9.78B
PROTAGONIST THERAPEUTICS, INC.	-.--%	-.--%	31.17x	-	16.31x	29.76x	29.07x	9.38B
ABIVAX	-.--%	-.--%	-25.56x	7.52x	90.48x	-25.51x	-43.14x	9.06B
QIAGEN N.V.	0.3%	0.41%	23.25x	2.46x	4.64x	12.47x	15.9x	9.26B
PRAXIS PRECISION MEDICINES, INC.	-.--%	-.--%	-21.51x	7.43x	8889.55x	-17.56x	-17.29x	8.34B
IMMUNOVANT, INC.	-.--%	-.--%	-12.59x	15.55x	-	-11.47x	-11.49x	7.68B
Average	0.2%	0.23%	16.15x	8.67x	519.89x	19.54x	-80.05x	18.64B
Weighted average by Cap.	0.25%	0.29%	21.01x	9.15x	248.74x	19.24x	-54.03x

Other Biotechnology & Medical Research

-40%: Exceptional extension

d

:

SEIZE THE OFFER!